New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development

Biochemical Pharmacology

Volumn 77, Issue 1, 2009, Pages 1-10

  Moreno, Juan J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Angiogenesis; Apoptosis; Cell proliferation; Cytochrome P 450; HETE; Lipoxygenase

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 16 HYDROXYICOSATETRAENOIC ACID; 17 HYDROXYICOSATETRAENOIC ACID; 18 HYDROXYICOSATETRAENOIC ACID; 19 HYDROXYICOSATETRAENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 8 HYDROXYARACHIDONIC ACID; CYTOKINE; GLUTATHIONE PEROXIDASE; GROWTH FACTOR; HYDROXYICOSATETRAENOIC ACID; LIPOXYGENASE; PROSTANOID; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; ICOSANOID METABOLISM; METASTASIS; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 56649118965     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.07.033     Document Type: Note

References (108)

1. Imig J.D. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 279 (2000) F965-F981
2. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
3. Kuhn H., and Thiele B.J. The diversity of the lipoxygenase family Many sequence data but little information on biological significance. FEBS Lett 449 (1999) 7-11
4. Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128 (1992) 117-131
5. Brash A.R., Boeglin W.E., and Chang M.S. Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci USA 94 (1997) 6148-6152
6. Jisaka M., Kim R.B., Boeglin W.E., and Brash A.R. Identification of amino acid determinats of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2. J Biol Chem 275 (2000) 1287-1293
7. Oliw E.H. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by bovine corneal epithelium. Acta Physiol Scand 147 (1993) 117-121
8. Liminga M., Fagerholm P., and Oliw E.H. Lipoxygenase in corneal epithelial of man and cynomolgus monkey. Exp Eye Res 59 (1994) 313-321
9. Scarborough P.E., Ma J., Qu W., and Zeldin D.C. P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab Rev 31 (1999) 205-234
10. Lin J.H.C., Kobari Y., Zhu Y., Stemerman M.B., and Pritchard K.A. Human umbilical vein endothelial cells express P450 2C8 mRNA: cloning of endothelial P450 epoxygenase. Endothelium 4 (1996) 219-229
11. Capdevila J., Yadagiri P., Manna S., and Falck J.R. Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450. Biochem Biophys Res Commun 141 (1986) 1007-1011
12. Bylund J., Kunz T., Valmsen K., and Oliw E.H. Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human. J Pharmacol Exp Ther 284 (1998) 51-60
13. Boeglin W.E., Kim R.B., and Brash A.R. A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc Natl Acad Sci USA 95 (1998) 6744-6749
14. Lecomte M., Laneuville O., Ji C., DeWitt D.L., and Smith W.L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 269 (1994) 13207-13215
15. Thuresson E.D., Lakkides K.M., and Smith W.L. Different catalytically competent arrangement of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. J Biol Chem 275 (2000) 8501-8507
16. Carroll M.A., Balazy M., Huang D.D., Rybalova S., Falck J.R., and McGiff J.C. Cytochrome P-450-derived renal HETEs: storage and released. Kidney Int 51 (1997) 1696-1702
17. McGiff J.C., and Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol 277 (1999) R607-R623
18. Mancini J.A., Waterman H., and Riendeau D. Cellular oxygenation of 12-hydroxyeicosatetraenoic acid by 5-lipoxygenase is stimulated by 5-lipoxygenase-activating protein. J Biol Chem 273 (1998) 32842-32847
19. Hoagland K.M., Maier K.G., Moreno C., Yu M., and Roman R.J. Cytochrome P450 metabolites of renal function. Nephrol Dial Transplant 16 (2001) 2283-2285
20. Roman R.J. P450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82 (2002) 131-185
21. Natarajan R., and Nadler J.L. Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol 24 (2004) 1542-1548
22. 2. J Biol Chem 263 (1988) 7567-7573
23. Nieves D., and Moreno J.J. Hydroxyeicosatetraenoic acids released through the cytochrome P450 pathway regulate 3T6 fibroblast growth. J Lipid Res 47 (2006) 2681-2689
24. Nieves D., and Moreno J.J. Role of 5-lipoxygenase pathway in the regulation of RAW 264 7 macrophage proliferation. Biochem Pharmacol 72 (2006) 1022-1030
25. Arora J.K., Lysz T.W., and Zelenka P.S. A role for 12(S)HETE in the response of human lens epithelial cells to epidermal growth factor and insulin. Invest Ophthalmol Vis Sci 37 (1996) 1411-1418
26. Ottino P., Taberi F., and Bazan H.E. Growth factor-induced proliferation in corneal epithelial cells is mediated by 12(S)-HETE. Exp Eye Res 76 (2003) 613-622
27. Lin F., Rios A., Falck J.R., Belosludtsev Y., and Schwartzman M.L. 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am J Physiol 269 (1995) F806-F816
28. Muthalif M.M., Benter I.F., Karzoun N., Fatima S., Harper J., Uddin M.R., et al. 20-hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated proteins kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 95 (1998) 12701-12706
29. Wilson S.E., Chen L., Mohan R.R., Liang Q., and Liu J. Effect of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res 68 (1999) 377-397
30. Lin N., Hurst J., and Bazan H.E. Increased synthesis of specific eicosanoid in rejected corneal grafts. Curr Eye Res 15 (1996) 1208-1212
31. Gupta A.G., Hirakata A., and Proia A.D. Effect of inhibitors of arachidonic acid metabolism on corneal reepithelialization in the rat. Exp Eye Res 56 (1993) 701-708
32. Pidgeon G.P., Tang K., Cai Y.L., Piasentin E., and Honn K.V. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. Cancer Res 63 (2003) 4258-4267
33. Hassan S., and Carraway R.E. Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-involved prostate cancer PC3 cell growth. Regul Pept 133 (2006) 105-114
34. Guo M., Roman R.J., Falck J.R., Edwards P.A., and Scicli A.G. Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of cytochrome P4504A. J Pharmacol Exp Ther 315 (2005) 526-533
35. Chang W.C., Ning C.C., Lin M.T., and Huang J.D. Epidermal growth factor enhances a microsomal 12-lipoxygenase activity in A431 cells. J Biol Chem 267 (1992) 3657-3666
36. Natarajan R., Bai W., Rangarajan V., Gonzales N., Gu J.L., Lanting L., et al. Platelet-derived growth factor BB mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells. J Cell Physiol 169 (1996) 391-400
37. Reddy M.A., Adler S.G., Kim Y.S., Lanting L., Rossi J., Kang S.W., et al. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol 283 (2002) F985-F994
38. Wen Y., Gu J., Peng X., Zhang G., and Nadler J. Overexpression of 12-lipoxygenase and cardiac fibroblast hypertrophy. Trends Cardiovasc Med 13 (2003) 129-136
39. Limor R., Sharon O., Knoll E., Many A., Wisinger G., and Stern N. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. Am J Hypertens 21 (2008) 219-223
40. Zeng Z.Z., Yellaturu C.R., Neeli I., and Rao G.N. Hydroxyeicosatetraenoic acid stimulates DNA synthesis in human microvascular endothelial cells via activation of Jak/STAT and phosphatidylinositol 3-kinase/AKT signalling, leading to induction of expression of basic fibroblast growth factor-2. J Biol Chem 277 (2002) 41213-41219
41. Tang D.G., Renaud C., Stojakovic S., Diglio C.A., Porter A., and Honn K.V. 12-S-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun 211 (1995) 462-468
42. Preston I.R., Hill N.S., Warburton R.R., and Fanburg B.L. Role of 12-lipoxygease in hypoxia induced rat pulmonary artery smooth muscle cell proliferation. Am J Physiol Cell Mol Physiol 290 (2006) L367-L374
43. Palmberg L., Lindgnen J.A., Thyberg J., and Claesson H.E. On the mechanism of induction of DNA synthesis in cultured arterial sooth muscle cells by leukotrienes. Possible role of prostaglandin endoperoxide synthase products and platelet-derived growth factor. J Cell Sci 98 (1991) 141-149
44. Uddin M.R., Muthalif M.M., Karzoun N.A., Benter I.F., and Malik K.U. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signalling. Hypertension 31 (1998) 242-247
45. 2 and 12- and 20-hydroxyeicosatetraenoic acids. J Cell Physiol 195 (2003) 92-98
46. Kang L.T., Phillips T.M., and Vanderhoek J.Y. Novel membrane target proteins for lipoxygenase-derived mono (S) hydroxy fatty acids. Biochim Biophys Acta 1438 (1999) 388-398
47. O'Flaherty J.T., Rogers L.C., Chadwell B.A., Owen J.S., Rao A., Cramer S.D., et al. 5(S)hydroxyl-6,8,11,14-E,Z,Z,Z-eicosatetraenoate stimulates PC3 cell signalling and growth by a receptor-dependent mechanism. Cardiovasc Res 62 (2002) 6817-6819
48. McCabe N.P., Selma S.H., and Jankun J. Vascular endothelial growth factor production in human prostate cancer cells in stimulated by overexpression of platelet 12-lipoxygenase. Prostate 66 (2006) 779-787
49. Szekeres C.K., Tang K., Trikka M., and Honn K.V. Eicosanoid activation of extracellular signal-regulated kinase 1/2 in human epidermoid carcinoma cells. J Biol. Chem 275 (2000) 38831-38841
50. Reddy M.A., Thimmalapura P.R., Lanting L., Nadler J.L., Fatima S., and Natarajan R. The oxidize lipid and lipoxygene product 12(S)hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation Mediation of angiotensin II effects. J Biol Chem 277 (2002) 992-9928
51. Nieves D., and Moreno J.J. Enantioselective effect of 12(S)-hydroxyeicosatetraenoic acid on 3T6 fibroblast growth through ERK 1/2 and p38 MAPK pathways and cyclin D1 activation. Biochem Pharmacol 76 (2008) 654-661
52. Pidgeon G.P., Kandouz M., Meram A., and Honn K.V. Mechanisms controlling cell cycle arrest in induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res 62 (2002) 2721-2727
53. Leung H.W., Yang W.H., Lai M.Y., Lin C.J., and Lee H.Z. Inhibition of 12 lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 45 (2007) 403-411
54. Yoshinaga M., Buchanan F.G., and Dubois R.N. 15-LOX-1 inhibits p21 (Cip/WAF-1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cells. Prostaglandins Other Lipid Mediat 73 (2004) 111-122
55. Kim E, Rundhaug JE, Benavides F, Yang P, Newman RA, Fisher SM. An antitumorigenic role of murine 8-S-lipoxygenase in skin carcinogenesis. Oncogene 24:1174-87.
56. Brinkman H.J., van Buul-Wortelboer M.F., and van Mourik J.A. Involvement of cyclooxygenase- and lipoxygenase-mediated conversion of arachidonic acid in controlling human vascular smooth muscle cell proliferation. Thomb Haemost 63 (1990) 291-297
57. Shappell S.B., Gupta R.H., Manning S., Whitehead R., Boeglin W.E., Schneider C., et al. 15 S-hydroxyeicosateraenoic acid activates peroxisome proliferators-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 61 (2001) 497-503
58. Andreasen A., Hansen E.S., Fogh K., Kragballe K., and Herlin T. Proliferation of adherent synovial fluid cell cultures is modified by eicosanoids. Acta Pathol Microbiol Immunol 98 (1990) 605-608
59. Schweiger D., Furstenberger G., and Krieg P. Inducible expression of 15-lipoxygenase-2 and 8-lipoxygenase inhibits cell growth via common signalling pathways. J Lipid Res 48 (2007) 553-564
60. Kelefiotis D., Bresnahan B.A., Stratidakis I., and Lianos E.A. Eicosanoid-induced growth and signaling events in rat glomerular mesangial cells. Prostaglandins 49 (1995) 269-283
61. Fujita H., Saito F., Sawada T., Kushiro T., Yagi H., and Kanmatsuse K. Lipoxygenase inhibition decreases neointimal formation following vascular injury. Atherosclerosis 147 (1999) 69-75
62. Avis I., Hong S.H., Martinez A., Moody T., Choi Y.H., Trepel J., et al. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell line through complex eicosanoid interactions. FASEB J 15 (2001) 2007-2009
63. Hussey H.J., and Tisdale M.J. Inhibition of tumour growth by lipoxygenase inhibitors. Br J Cancer 74 (1996) 683-687
64. Ding X.Z., Talamonti M.S., Bell R.H., and Adrian T.E. A novel anti-pancreatic cancer agent LY293111. Anticancer Drugs 16 (2005) 467-473
65. Avis I.M., Jett M., Boyle T., Vos M.D., Moody T., Treston A.M., et al. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97 (1996) 806-813
66. Wen Y., Gu J., Peng X., Zhang G., and Nadler J. Overxpression of 12-lipoxygenase and cardiac fibroblast hypertrophy. Trends Cardiovasc Med 13 (2003) 129-136
67. Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathway. Int J Biochem cell Biol 2007;39:1248-59.
68. Ding X.Z., Tong W.G., and Adrian T.E. 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation. Int J Cancer 94 (2001) 630-636
69. Nie D., Krishnamoorthy S., Jin R., Tang K., Chen Y., Quia Y., et al. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem 281 (2006) 18601-18609
70. Chen F.L., Wang X.Z., Li J.Y., Yu J.P., Huang C.Y., and Chen Z.X. 12-lipoxygenase induces apoptosis of human gastric cancer AGS cells via the ERK 1/2 signal pathway. Dig Dis Sci 53 (2008) 181-187
71. Brinkman H.J., van Buul-Wortelboer M.F., and van Mourik J.A. Involvement of cyclooxygenase- and lipoxygenase-mediated conversion of arachidonic acid in controlling human vascular smooth muscle cell proliferation. Thromb Haemost 63 (1990) 291-297
72. Vernhet L., Hichami A., Hamon L., Cochet M.F., and Legrand A.B. Incorporation of 12(S)-hydroxyeicosatetraenoic acid into phospholipids and active diacylglycerols in rat liver epithelial cells: effects on DNA synthesis. J Lipid Mediat Cell Signal 13 (1996) 233-248
73. Tang S., Bhatia B., Maldonado C.J., Yang P., Newman R.A., Liu J., et al. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 277 (2002) 16189-16201
74. Mahipal S.V.K., Subhashini J., Reddy M.C., Reddy M.M., Anilkumar K., Roy K.R., et al. Effect of 15-lipoxygenase metabolites 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis. Biochem Pharmacol 74 (2007) 202-214
75. Claria J., Lee M.H., and Serhan C.N. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med 2 (1996) 583-596
76. Vang K., and Ziboh V.A. 15-lipoxygenase metabolites of gamma-linolenic acid/eicosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: possible implications of dietary fatty acids. Prostaglandins Leukot Essent Fatty Acids 75 (2005) 363-372
77. Nishio E., and Watanabe Y. The regulation of mitogenesis and apoptosis in response to the persistent stimulation of alpha1-adrenoreceptors: a possible role of 15-lipoxygenase. Br J Pharmacol 122 (1997) 1516-1522
78. Tang D.G., Guan K.L., Li L., Honn K.V., Chen Y.Q., Rice R.L., et al. Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. Int J Cancer 72 (1997) 1078-1087
79. Lovat P.E., Oliverio S., Ranalli M., Corazzari M., Rodolfo C., Bernassola F., et al. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res 62 (2002) 5158-5167
80. Catalano A., Caprari P., Soddu S., Procopio A., and Romano M. 5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking. FASEB J 18 (2004) 1740-1742
81. Romano M., Catalano A., Nutini M., D'Urbano E., Crescenzi C., Claria J., et al. 5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endotelial growth factor. FASEB J 15 (2001) 2326-2336
82. Tang D.G., Renaud C., Stojakovic S., Diglio C.A., Porter A., and Honn K.V. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun 211 (1995) 462-468
83. Nie D., Tang K., Diglio C., and Honn K.V. Eicosanoid regulation of angiogenesis: role of endotelial arachidonate 12-lipoxygenase. Blood 95 (2000) 2304-2311
84. Tang F.G., Grossi I.M., Chen Y.Q., Deglio C.A., and Honn K.V. 12(S)HETE promotes tumor-cell adhesion by increasing surface expression of alpha v beta 3 integrins on endothelial cells. Int J Cancer 54 (1993) 102-111
85. Guo A.M., Arbad A.S., Falck J.R., Chen P., Edwards P.A., Roman R.J., et al. Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther 321 (2007) 18-27
86. Nie D., Nemeth J., and Qiao Y. Increased metastasic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metastasis 20 (2003) 657-663
87. Ye Y.N., Liu E.S., Shin V.Y., Wu W.K., and Cho C.H. Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking. Toxicol 203 (2004) 179-188
88. Timar J., Tang D., Bazaz R., Haddad M.M., Kimler V.A., Taylor J.D., et al. PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells. Cell Motil Cytoskel 26 (1993) 49-65
89. Ulbricht B., Hagmann W., Ebert W., and Spiess E. Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxyeicosatetraenoic acid. Exp Cell Res 226 (1996) 255-263
90. Timar J., Bazaz R., and Honn K.V. Immunomorphological characterization and effects of 12-(S)-HETE on a dynamic intracellular pool of the alpha IIb beta 3-integrin in melanoma cells. J Cell Sci 108 (1995) 2175-2186
91. Honn K.V., Grossi I.M., Diglio C.A., Wojtukiewicz M., and Taylor J.D. Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction. FASEB J 3 (1989) 2285-2293
92. Nony P.A., Kennett S.B., Glasgow W.C., Olden K., and Roberts J.D. 15-S-lipoxygenase-2 mediates arachidonic acid-stimulated adhesion of human breast carcinoma cells through the activation of TAK1, MKK6, and p38 MAPK. J Biol Chem 280 (2005) 31413-31419
93. Jiang W.G., Watkins G., Douglas-Jones A., and Mansel R.E. Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer. Prostaglandins, Leukotrienes Essent Fatty Acids 74 (2006) 235-245
94. Jiang W.G., Douglas-Jones A.G., and Mansel R.E. Aberrant expression of 5-lipoxygenase-activating proteins (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Prostaglandins, Leukotrienes Essent Fatty Acids 74 (2006) 125-134
95. Shureiqi I., Wu Y., Chen D., Yang X.L., Guan B., Morris J.S., et al. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res 65 (2005) 11486-11492
96. Nithipatikom K., Isbell M.A., See W.A., and Campbell W.B. Elevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases. Cancer Lett 233 (2006) 219-225
97. Freedman R.S., Wang E., Voiculescu S., Patenia R., Bassett R.L., Deavers M., et al. Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer. Clin Cancer Res 13 (2007) 5736-5744
98. Piao Y.S., Du Y.C., Oshima H., Jin J.C., Nomura M., Yoshimoto T., et al. Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency. Carcinogenesis 29 (2008) 440-447
99. Moreno J.J. Arachidonic acid cascade enzyme inhibition and cancer. Curr Enzyme Inhib 1 (2005) 131-145
100. Bednar W., Holzmann K., and Marian B. Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme. Food Chem Toxicol 45 (2007) 508-514
101. Rioux N., and Castonguay A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis 19 (1999) 1393-1400
102. Wu J., Xia H.H., Tu S.P., Fan D.M., Lin M.C., Kung H.F., et al. 15-lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. Carcinogenesis 24 (2003) 243-247
103. Shureiqi I., and Lippman S.M. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61 (2001) 6307-6312
104. Rao C.V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V., et al. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroideal anti-inflammatory agent. Cancer Res. 55 (1995) 1464-1472
105. Gupta S., Srivastava M., Ahmad N., Sakamoto K., Bostwick D.G., and Mukhtar H. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 91 (2001) 737-743
106. Chen X., Li N., Wang S., Hong J., Fang M., Yousselfson J., et al. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effect of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethyl ornithine on tumorigenesis in a rat surgical model. Carcinogenesis 23 (2002) 2095-2102
107. Tan W., Wu J., Zhang X., Liu J., Sun T., Zhang B., et al. Association of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis 28 (2007) 1197-1201
108. Guo M., Roman R.J., Fenstermacher J.D., Brown S.L., Falck J.R., Arbab A.S., et al. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N′-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A. J Pharmacol Exp Ther 317 (2006) 97-108